Derma Sciences (DSCI) Tops Q2 EPS by 6c

Derma Sciences (NASDAQ: DSCI) reported Q2 EPS of ($0.36), $0.06 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.66 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Community West Bancshares (CWBC) Misses Q2 EPS by 20c
• World Acceptance (WRLD) Tops Q1 EPS by 168c